Management of hyperlipidemia in diabetes mellitus

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Accelerated atherosclerosis is a major complication of long-term diabetes mellitus, and this is partly due to associated abnormalities of lipoprotein metabolism. Hypertriglyceridemia is usually due to poorly controlled diabetes and responds to improved glucose control. Hypercholesterolemia is usually not related to poor diabetic control and should be treated with a cholesterol lowering diet and drugs according to the National Cholesterol Education Program guidelines. Low HDL-C is common in NIDDM and does not fully return to normal with improved diabetic control. Dyslipidemia in diabetics should be aggressively identified and treated to decrease cardiovascular risk.

Original languageEnglish (US)
Pages (from-to)395-414
Number of pages20
JournalEndocrinology and Metabolism Clinics of North America
Volume21
Issue number2
StatePublished - 1992

Fingerprint

Medical problems
Hyperlipidemias
Diabetes Mellitus
Cholesterol
Hypertriglyceridemia
Dyslipidemias
Hypercholesterolemia
Type 2 Diabetes Mellitus
Lipoproteins
Atherosclerosis
Guidelines
Nutrition
Diet
Education
Metabolism
Glucose
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Management of hyperlipidemia in diabetes mellitus. / Dunn, F. L.

In: Endocrinology and Metabolism Clinics of North America, Vol. 21, No. 2, 1992, p. 395-414.

Research output: Contribution to journalArticle

@article{7f827e8185794d8bbe5f3bd0f4b98262,
title = "Management of hyperlipidemia in diabetes mellitus",
abstract = "Accelerated atherosclerosis is a major complication of long-term diabetes mellitus, and this is partly due to associated abnormalities of lipoprotein metabolism. Hypertriglyceridemia is usually due to poorly controlled diabetes and responds to improved glucose control. Hypercholesterolemia is usually not related to poor diabetic control and should be treated with a cholesterol lowering diet and drugs according to the National Cholesterol Education Program guidelines. Low HDL-C is common in NIDDM and does not fully return to normal with improved diabetic control. Dyslipidemia in diabetics should be aggressively identified and treated to decrease cardiovascular risk.",
author = "Dunn, {F. L.}",
year = "1992",
language = "English (US)",
volume = "21",
pages = "395--414",
journal = "Endocrinology and Metabolism Clinics of North America",
issn = "0889-8529",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Management of hyperlipidemia in diabetes mellitus

AU - Dunn, F. L.

PY - 1992

Y1 - 1992

N2 - Accelerated atherosclerosis is a major complication of long-term diabetes mellitus, and this is partly due to associated abnormalities of lipoprotein metabolism. Hypertriglyceridemia is usually due to poorly controlled diabetes and responds to improved glucose control. Hypercholesterolemia is usually not related to poor diabetic control and should be treated with a cholesterol lowering diet and drugs according to the National Cholesterol Education Program guidelines. Low HDL-C is common in NIDDM and does not fully return to normal with improved diabetic control. Dyslipidemia in diabetics should be aggressively identified and treated to decrease cardiovascular risk.

AB - Accelerated atherosclerosis is a major complication of long-term diabetes mellitus, and this is partly due to associated abnormalities of lipoprotein metabolism. Hypertriglyceridemia is usually due to poorly controlled diabetes and responds to improved glucose control. Hypercholesterolemia is usually not related to poor diabetic control and should be treated with a cholesterol lowering diet and drugs according to the National Cholesterol Education Program guidelines. Low HDL-C is common in NIDDM and does not fully return to normal with improved diabetic control. Dyslipidemia in diabetics should be aggressively identified and treated to decrease cardiovascular risk.

UR - http://www.scopus.com/inward/record.url?scp=0026647109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026647109&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 395

EP - 414

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

IS - 2

ER -